Divis Laboratories Ltd | DIVI - Interest Expense On Debt

Stock Price
6,271.50
Daily Change
-19.50 -0.31%
Monthly
3.56%
Yearly
9.98%
Q1 Forecast
6,171.47

Divis Laboratories Ltd reported INR60M in Interest Expense on Debt for its fiscal quarter ending in December of 2025.





Interest Expense On Debt Change Date
Alaunos Therapeutics USD 0 0 Dec/2023
Aurobindo Pharma INR 927.7M 24.7M Dec/2025
Avita Medical AUD 1.25M 100K Jun/2025
Dianthus Therapeutics USD 4.44M 263K Sep/2024
Divis Laboratories Ltd INR 60M 30M Dec/2025
Ionis Pharmaceuticals USD 18M 1000K Sep/2025
IQVIA Holdings USD 193M 4M Dec/2025
Lupin INR 1.15B 73.9M Dec/2025
Moderna USD 12.14B 12.13B Sep/2025
Organon & Co USD 128M 3M Sep/2025
Revvity USD 23.51M 742K Dec/2025
Tectonic Therapeutic USD 277M 276.98M Sep/2025
Tilray USD 6.7M 2.73M Jun/2025
Viatris USD 119.6M 3M Sep/2025
Xeris Pharmaceuticals USD 7.27M 92K Sep/2025